Japan's Rohto and Mitsui to buy Chinese-medicine chain for $590m

Partners tap rising health interest after pandemic to expand overseas

20240404N Eu Yan Sang

Eu Yan Sang operates over 170 stores selling traditional Chinese medicine across Asia. (Eu Yan Sang)

YUKI MISUMI, Nikkei staff writer

OSAKA -- Rohto Pharmaceutical and trading house Mitsui & Co. will acquire traditional Chinese medicine company Eu Yan Sang International for about 800 million Singapore dollars ($594 million), the Japanese companies said Thursday.

Singapore-based Eu Yan Sang is the largest traditional Chinese medicine chain in Southeast Asia and a well-known name in Hong Kong. It operates over 170 stores and 30 Chinese herbal medicine clinics, mostly in Malaysia, Hong Kong and Singapore.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.